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Over the last 150 years the developed world has experienced a 
dramatic decline in the incidence and prevalence of rheumatic 
fever and rheumatic heart disease (RF/RHD) through improved 
living conditions and the widespread use of penicillin for the 
treatment of streptococcal pharyngitis. Despite the proven 
effectiveness and availability of penicillin for both primary and 
secondary prevention of RF, developing countries continue to 
face unacceptably high rates of the disease. 1 
RF /RHD is the most common cardiovascular disease in 
children and young adults in the world, because 80% of the 
world's population live in developing countries where the 
disease is still rampant. Recent research estimates that RF /RHD 
affects about 15.6 million people worldwide, with 282 000 new 
cases and 233 000 deaths each year. There are 2.4 million affected 
children between 5 and 14 years of age in developing countries, 
1 million of whom live in sub-Saharan Africa, making the 
continent the major RF/RHD hotspot.2 
A recent systematic review of prevalence studies found 
exceptionally high rates of RHD in sub-Saharan Africa, with 
the highest level in Kinshasa, DRC at 14/1 000 school-aged 
children.3A The only prevalence data available on RHD for 
South Africa are derived from two studies dating back to 
1972 and 1984 which estimated the prevalence using clinical 
examination (no echocardiography) in Soweto (Johannesburg) 
and Inanda (Durban) at 7.1/1 000 schoolchildren and 1.0/1 000 
schoolchildren, respectively.5•6 
As a middle-income country South Africa would be expected 
to have more capacity than other countries in the region for 
developing and implementing a national RF /RHD intervention 
programme; however, South Africa has fallen short in its control 
efforts. A local assessment of the country's national guidelines7 
on the secondary prevention of RF found that as of 2004, little 
progress had been made towards implementing the guidelines 
which have been in existence since 1997.7 Concerted efforts 
to control RF /RHD must be bolstered as soon as possible in 
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the developing world so that progress can be made towards 
eradicating what is an entirely preventable disease. 
Programme description 
The Awareness, Surveillance, Advocacy, Prevention (A.S.A.P.) 
proposal is a comprehensive programme for the control of RF 
and RHD that was adopted at the 1st All Africa Workshop 
on Rheumatic Fever and Rheumatic Heart Disease at the 
Champagne Sports Resort, Drakensberg, South Africa on 15- 16 
October 2005. The meeting was convened by the Pan African 
Society of Cardiology (PASCAR), sponsored by the national 
Department of Health of South Africa, the Medical Research 
Council of South Africa, the World Health Organization -
Africa Office (WHO-AFRO), and the World Heart Federation, 
and endorsed by the South African Heart Association and the 
Paediatric Cardiology Society of South Africa. The workshop 
was attended by a total of 42 delegates, from Angola (1), 
Cameroon (1), Congo (1), Egypt (1), Ghana (1), Mozambique (2), 
Nigeria (3), South Africa (27), and Zimbabwe (2). There were 
also speakers from Australia (1), the Netherlands (1), and the 
USA (1). 
The components of the A.S.A.P. model adopted at the 
workshop include: Awareness raising, a Surveillance system, an 
Advocacy campaign, and a Preventio n programme. 
The objective for developing A.S.A.P. is to create a simple, 
modular but comprehensive model for RF/RHD control in 
Africa, based on interventions of proven efficacy, which can be 
adopted in part or in toto by national departments of health or 
non-governmental organisations with a commitment to reducing 
the burden of disease attributable to RF /RHD in Africa. This 
document presents: (i) the rationale; (ii) barriers; (iii) best 
practice of what works; and (iv) action points (online) in relation 
to the four focus areas of A.S.A.P. 
Awareness raising 
Rationale 
RF /RHD case detection is an essential component of the A.S.A.P. &II 
model. In the absence of adequate case detection, the magnitude 
of the RF /RHD burden cannot be estimated accurately and 
undetected cases will not receive treatment and antibiotic 
prophylaxis. Maximised case detection within a community 
requires that all key members of the community be aware and 
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alert to the risks and signs of both the preceding streptococcal 
pharyngitis and to RF. Awareness must be highest among child 
caregivers, teachers and health care workers, especially those 
likely to be the initial point of contact with the health care 
system. 
Barriers 
There are several explanations for the low levels of awareness 
of RF IRHD in communities often most affected by the disease.7 
One of these barriers arises from the reality that communities 
at highest risk for RF IRHD are also frequently burdened 
with high rates of other major diseases such as HIV I AIDS 
and tuberculosis. These diseases inevitably receive higher 
priority from those in charge of distributing scarce resources 
for disease-control programmes. Inadequate resources and the 
lack of prioritisation of RF/RHD educational programmes have 
effectively maintained a public that is largely ignorant of the 
causes, symptoms and risks associated with RFIRHD.7 
Another barrier was identified through interviews with 
children who have suffered an acute attack of RF and their 
family members in the Western Cape of South Africa? It is 
assumed that patients and their parents receive extensive 
information on the causes, course of disease, and importance of 
adhering to secondary prophylaxis from the treating physician 
at the time of diagnosis. Yet the interviews revealed high 
levels of ignorance among this group suggesting that they 
either had not received the appropriate information, or had 
not understood the information when it was given to them? 
The complex aetiology and pathogenesis of this disease make 
knowledge transfer to the patient difficult but no less essential. 
Best practice 
Community awareness has been found to be essential for case 
detection. A 10-year educational programme, undertaken 
in two French Caribbean Islands beginning in 1981 which 
sought to reduce the incidence of RF, provides evidence for 
the link between awareness and case detection.8 One year 
after implementing an educational campaign that consisted 
of widely distributed pamphlets and posters, television 
advertisements and educational videos, the reported cases of 
RF increased 10- 20%. This increase was entirely attributed 
to an increased awareness of the disease in the community. 
The studl also found that over the course of the 10-year 
educational intervention, the incidence of RF progressively 
declined on both islands by 74- 78%. These findings support 
the argument that a community-based educational programme 
aimed at raising awareness of RF is essential for case detection 
and may be a critical first step in a comprehensive plan for RF I 
RHDcontrol. 
The Bach study8 also highlights the importance of addressing 
the elements of RF IRHD control not as discrete entities but 
as interconnected principles with efficacy levels reliant on the 
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successful execution of activities in all areas. The example 
above illustrates the importance of raising community 
awareness to improve incidence reporting. The reciprocal 
relationship also holds, whereby incidence reporting is a 
valuable tool for monitoring and evaluation of the effectiveness 
of an educational programme in reducing the burden of RF I 
RHD. In order to take advantage of this reciprocal relationship, 
community RF IRHD control programmes should combine the 
efforts of raising awareness with incidence reporting. 
Awareness among health care workers of the importance 
of treating streptococcal pharyngitis with antibiotics, the 
appropriate method for diagnosing RF (using the revised 
Jones criteria),' and the obligation of case reporting to local 
authorities, where RF is a notifiable condition (such as in South 
Africa), is also needed for a functional RF IRHD control system. 




As highlighted by the 2001 World Health Organization (WHO) 
Report on RF and RHD/ collection of epidemiological data 
is a crucial step in planning and implementing a national 
programme for the prevention and control of RF and RHD. 
Epidemiological data allow policymakers and practitioners to 
identify groups or locations that are most affected by RF IRHD 
in order to direct and concentrate control efforts appropriately. 
Ongoing surveillance of the incidence of RF and the prevalence 
of RHD is therefore the second pillar of the A.S.A.P. model, 
which has a symbiotic relationship with an awareness-raising 
campaign, the critical first step. 
The current state of RF IRHD surveillance programmes 
in countries most affected by the disease is deficient.1 The 
aforementioned systematic review4 of RHD prevalence 
studies highlights the lack of quality prevalence data and 
the absence of reports on RF outbreaks from developing 
countries. The scarcity of reliable surveillance data has been 
one of many barriers preventing developing countries from 
mounting an appropriate and effective response to combat 
RF IRHD. Therefore, an immediate priority for getting the 
A.S.A.P. programme off the ground is to bolster surveillance 
programmes in a step-by-step fashion to achieve the 
establishment of a sustainable comprehensive surveillance 
system. 
Barriers 
Barriers to effective surveillance of RF /RHD are multiple 
but tend to be rooted in the following: (i) lack of surveillance 
capacity; (ii) lack of awareness among health professionals 




awareness among the public to ensure accurate case 
detection/ and (iv) lack of political will on the part of national 
departments of health. 
Best practice - the stepwise approach to surveillance 
The stepwise approach to RF/RHD surveillance advocated in 
the A.S.A.P. programme is modelled after the 'WHO STEPwise 
approach' used to collect epidemiological data on risk factors 
for non-communicable diseases in developing countries.10 The 
approach is based on the premise that in resource-constrained 
settings the collection of a small amount of accurate data is 
more valuable than large quantities of inaccurate data or no 
data at all. The ultimate goal of the stepwise approach is to 
eventually create a sustainable comprehensive national and 
continental surveillance system by achieving smaller, more 
realistic goals one step at a time. 
The following steps are recommended to implement a RF I 
RHO surveillance system. The achievement of each subsequent 
step requires increased surveillance capacity so the plan should 
be followed in a progressive manner. Each step requires the 
establishment of several sentinel sites that capture high-risk 
populations living in a variety of environmental conditions. 
In order to evaluate the effects of various environmental 
conditions on the risk of developing RF, sentinel sites should 
capture rural, peri-urban and urban populations: Step 1: 
Creation and maintenance of RF /RHO registers, Step 2: 
Prospective RF incidence surveys, Step 3: Cross-sectional RHO 
prevalence surveys, and Step 4: Epidemiology of streptococcal 
throat and skin infections. 
Step 1. The creation and maintenance of a register or 
database of RF /RHO cases is a proven strategy for the 
secondary prevention of the disease. 11 It can also be used as a 
tool for case management to track cases and ensure that they 
are receiving appropriate prevention and treatment. Registers 
have been implemented successfully in several developing 
countries at low cost using existing infrastructure. The 
establishment of registers is a minimum requirement that can 
be achieved in almost any setting where the will to establish a 
RF /RHO control programme exists. The registers may be used 
as a basis for incidence (step 2) and prevalence (step 3) studies 
ofRF/RHD. 
Step 2. Owing to their intrinsic relatedness, prospective 
RF incidence studies should be incorporated into a health 
education campaign aimed at raising awareness of RF/RHD. 
The incidence studies will monitor and evaluate the efficacy 
of the awareness campaign, while the awareness campaign 
will improve the level of case detection thereby improving the 
quality of incidence data. 
The A.S.A.P. model recommends as step 2 of the 
surveillance initiative, the implementation of a medium-term 
pilot programme (e.g. 5 years) that combines community 
awareness building with incidence surveillance at a sentinel 
site. Elements of the programme that are continuous over 
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several years include health education activities and passive 
incidence reporting through pre-existing reporting systems. 
Every 3 years, beginning 1 year after the implementation of the 
education programme (to maximise case detection), a formal 
prospective incidence survey relying on active surveillance 
activities should be undertaken. The goals of this intermittent 
active surveillance are: (i) to obtain more accurate incidence 
data (including baseline data); (ii) to improve existing reporting 
practices by highlighting discrepancies between active and 
passive surveillance datasets; and (iii) to more accurately 
monitor and evaluate the impact of the awareness campaign on 
RF incidence. 
Following completion of the initial cycle of the pilot 
programme at a sentinel site, a permanent system should be 
implemented at national level for maintaining community 
awareness of RF /RHO and for maintaining the accuracy of 
passive disease reporting. 
Step 3. A prevalence study is an important element in 
the progression of surveillance activities as it provides 
a snapshot view of the burden of disease in a defined 
population. The recommended study design is one that 
utilises echocardiography to detect clinical and subclinical 
evidence of RHO in school-aged children in a defined 
population. The resources needed for executing a prevalence 
study are substantial owing to the required investment in 
echocardiography machines and trained staff. 
Step 4. The fourth step is to monitor the epidemiology of 
streptococcal throat and skin infections in the population. 
Patterns of streptococcal infection, related to infection rates 
and serological typing, exhibit seasonal and geographical 
variations. Describing these variations provides a more 
complete understanding of the epidemiology of RF /RHO, 
thereby improving the capacity to identify high-risk 
populations and increasing the likelihood of detecting 
outbreaks. This information is vital for the development of 
effective vaccines for streptococcal infection. 
According to the revised Jones criteria, laboratory 
confirmation of RF requires evidence of a preceding group A 
streptococcal (GAS) infection- indicated by at least 1 elevated 
antibody titre. The most common antibody tests include anti-
streptolysin-a (ASOT) and antideoxyribonuclease B, with 
serum levels peaking 3- 4 weeks after an acute RF attack.9 
Therefore, laboratory services needed to support a GAS 
monitoring programme include the ability to test for antibodies 
to streptococcus, ability to culture throat swab samples, and 
the capacity to provide GAS serological and genetic typing. Rg 
Because of the absence and/ or inadequate capacity of the 
microbiological infrastructure in developing countries, the 
fulfillment of this step will require significant improvements in 
all other surveillance areas and discrete investment to improve 
laboratory capacity at all service levels. 
The 2001 WHO report on RF /RHD9 highlights the critical 
role that microbiological laboratories play in both primary and 
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secondary RF /RHD prevention programmes. The report also 
provides recommendations for the establishment of laboratory 
capacity at each level of care. Recommended levels range from 
peripheral laboratory facilities capable of immediate testing to 
international reference laboratories capable of co-ordinating 
regional GAS epidemiological information. 




Effective methods of RF /RHD prevention have been available 
for over 50 years, yet the developing world has not succeeded 
in controlling the disease.12'13 Conversely, the developed world 
has succeeded in nearly eradicating the disease, resulting in 
the unfortunate side-effect of de-emphasising the persistent toll 
it takes on populations around the globe. Advocacy is needed 
to reverse this trend and to spotlight the devastating effects of 
RF /RHD on the health of the majority of children worldwide.2 
A population affected by RF /RHD that requires immediate 
attention and resources is the current cohort of patients with 
RHD who require medical and surgical intervention to repair 
or replace faulty heart valves.14 There is also a need to provide 
facilities for monitoring of anticoagulation in patients who 
have received mechanical heart valves. The latter facilities are 
woefully inadequate in developing countries.15 
Proper treatment for existing RHD must be prioritised 
alongside enhanced prevention efforts. Increased surveillance 
is urgently needed to quantify the burden associated with RHD 
in order to support the advocacy efforts needed to persuade 
governments to increase resources for the management of 
patients with rheumatic valve disease. 
Barriers 
The barriers preventing an adequate level of government 
prioritisation for RF /RHD include: (i) competition with larger-
scale health problems; (ii) lack of reliable epidemiological data 
that can be used to quantify the burden of RF /RHD; (iii) lack 
of public demand for increased prioritisation because of low 
levels of awareness; and (iv) a drop in prioritisation of RF I 
RHD on the international health agenda. 
Advocacy action plan 
mJ See Annex C www.pascar.org 
Prevention 
Rationale 
The prevention of RF /RHD can be achieved through two 
discrete strategies, namely primary and secondary prevention. 
Primary prevention works by treating the preceding 
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streptococcal infection with antibiotics. Secondary prevention 
is used after the initial RF attack to prevent the recurrence of 
RF and progression to RHD. Secondary prevention requires 
the prolonged or life-long administration of regular antibiotic 
injections. Both primary and secondary prevention strategies 
have been shown to be efficacious and cost-effective for the 
prevention of RF. 12'13 
Barriers 
Some of the barriers that can make primary prevention 
programmes difficult in the developing world include: (i) 
lack of awareness among the public and health care providers 
with regard to the link between streptococcal infection and 
RF; (il) lack of policy for the prevention of RF based on use 
of antibiotics in the appropriate setting; and (iii) the high 
prevalence of subclinical GAS infection.1 
Some of the barriers to effective secondary prevention 
programmes include: (i) the burden of making regular trips 
to the clinic for penicillin injections; (ii) migration of patients 
in developing country settings, making continuity of care 
difficult; (iii) patient fear of intravenous injections; and (iv) 
perceived risk on the part of health care providers of inducing 
anaphylactic shock.12 
Best practice 
The prevention strategy recommended in the A.S.A.P. model is 
grounded in the evidence on efficacy and therefore advocates 
for the implementation of both primary and secondary 
prevention programmes in the developing country setting.12•13 
Because the A.S.A.P. model includes as one of its core 
principles the implementation of an education programme to 
increase awareness of RF /RHD, including primary prevention 
as one of its key messages does not require much additional 
investment. It is logical to implement all proven strategies 
to prevent the occurrence of RF whenever possible. The 
additional benefits gained through primary prevention add 
minimal costs to the programme yet yield the added benefit of 
preventing the burdensome and prolonged nature of secondary 
prevention for its benefactors.13 
Prevention action plan 
See www.pascar.org 
Moving forward 
Implementing national A.S.A.P. programmes 
The first step to implementing a national A.S.A.P. programme 
is to create a National Advisory Committee on RF /RHD under 
the auspices of the Ministry of Health. The Committee would 
serve as the primary decision-making body of the programme 
and would be responsible for designing, implementing and 
adapting the A.S.A.P. model to fit the needs of the country. 
Committee members would consist of key stakeholders in the 
programme such as nurses, family physicians, paediatricians, 
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cardiologists, microbiologists, epidemiologists, policymakers, 
administrators and planners. 
The initial task for the National Advisory Committee should 
be to perform an assessment of the current state of RF /RHD 
control in the country. This assessment should include: (i) 
the identification of specific barriers to control efforts; (ii) 
a review of the current investment and pattern of resource 
allocation for RF /RHD control; (iii) an assessment of the health 
infrastructure available to support programme activities; and 
(iv) any other situation analysis the Committee deems valuable. 
Once these assessments have been made, the Committee 
should then proceed with the design and implementation of 
specific elements of the A.S.A.P. programme. A timeline for the 
progressive implementation of programme activities will be an 
essential element to ensure an objective-led plan for RF/RHD 
control. 
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